Reginald Williams

Reginald Williams leads teams that deliver research, analytic, and strategic support to clients, with a focus on the needs of life sciences manufacturers and patient groups.

He advises clients on medical technology policy, regulatory, and market access strategies for new products and the evolution of public and private payers' use of evidence for formulating coverage and reimbursement decisions, with a focus on the Medicare program.

Prior to joining Avalere, Reggie was a member of the health policy team at the National Academy of Social Insurance (NASI). He served as the Howard R. Swearer Public Service intern in the Rhode Island Department of Health's Office of Minority Health.

Reggie has an AB in biomedical ethics from Brown University. He serves on the board of directors of Mental Health America, a nonprofit dedicated to helping people live mentally healthier lives. He is a Patient-Centered Outcomes Research grant reviewer and a member of NASI and Health Technology Assessment International.

Authored Content

With increasing legislative and regulatory activity promoting adoption of digital health, interest has continued to expand in 2019.

Healthcare, like many areas of modern life, has been transformed by the internet and related digital technologies.

The National Academies issued a report identifying several key factors and recommendations for integrating social care into healthcare delivery.

It is no surprise that innovation in the world of digital health is transforming the way healthcare is delivered.

As technology comes to the forefront in healthcare innovation, the venture capital arms of many pharmaceutical companies are solidifying their presence as key investors.

Avalere experts hosted a lively discussion on current trends in digital health and the key steps necessary for stakeholders across the industry to successfully implement digital health initiatives.

The Centers for Medicare & Medicaid Services (CMS) is embracing digital health and virtual care in many ways.

Tune in to our podcast series where guest presenters explore the value of the newly released Alzheimer’s Association appropriate use criteria for lumbar puncture and cerebral spinal fluid (CFS) testing in the diagnosis of Alzheimer’s disease. Dr. Steven Salloway, Director of Neurology and the Memory and Aging Program at Butler Hospital, discusses how the Alzheimer’s Association’s new appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease will be helpful to clinicians in the diagnostic process.

In the final episode of our digital health podcast series, we interview Martha Lawrence, Chief Executive Officer of AccendoWave, discussing how technology has the promise to reduce pain for patients as an alternative to opioids. AccendoWave's system assesses patient discomfort levels using EEG technology.

Tune in to the third episode of our digital health podcast series as we explore the role innovation and technology play in the healthcare landscape. Today, we interview Sajid Ahmed, Chief Information & Innovation Officer of the new Martin Luther King Jr. Community Hospital. Hear how he leads its greater than $70 million health information technology initiative and launched the innovation hub that serves 1.35 million residents from all over South Los Angeles.

In episode 2 of our health technology podcast series, we discuss the promise of telehealth technologies with Jamey Edwards, CEO of Cloudbreak Health.

We are excited to bring you a 4-part podcast series dedicated to digital health where we explore the role innovation and technology play in healthcare. We kick off this series with Adam Kaufman, CEO of Canary Health. Canary Health is a leading digital health self-management platform, which has demonstrated success in helping people achieve improved health while lowering healthcare costs.

During the last week of October, Avalere invited a select group of innovators to breakfasts in Los Angeles and San Francisco to discuss elements of successful adoption of innovative technologies and models of care.

Earlier this week, BioCentury featured guest commentary from Tanisha Carino and Reginald Williams about patient engagement.

The 2014 market will be characterized by challenge and transformation across payers, providers, and patients which will create pressures for the pharmaceutical and medical device industries to:

Avalere convened a meeting of healthcare leaders who outlined four critical areas to sustain innovation: infrastructure, evidence evaluation, evidence communication, and coverage and payment.